Topics
Glioblastoma | Overall management | Bibliometric analyses
Home > Publications > Topics > Glioblastoma > Overall management > Bibliometric analyses
◽
Akmal M, Hasnain N, Rehan A, Iqbal
U, Hashmi S, Fatima K, Farooq MZ, Khosa F, Siddiqi J, Khan MK.
Glioblastome
Multiforme: A Bibliometric Analysis.
World
Neurosurg. 2020
Jan 14;136:270-282.
doi:
10.1016/j.wneu.2020.01.027. PMID:
31953095. Bibliometric analysis. ˍ
Articles
Miao
L, Zhang J, Zhang Z, Wang S, Tang F, Teng M, Li Y.
A
Bibliometric and
Knowledge-Map
Analysis of CAR-T Cells From 2009 to 2021.
Front
Immunol. 2022 Mar 18;13:840956∟.
doi: 10.3389/fimmu.2022.840956∟.
PMID: 35371087∟.
Bibliometric analysis. ˍ
◽
Nieder
C, Astner ST, Grosu AL.
Glioblastoma
research 2006-2010: pattern of citation and systematic review of
highly cited articles.
Clin
Neurol Neurosurg. 2012
Nov;114(9):1207-10∟.
doi: 10.1016/j.clineuro.2012.03.049∟.
Epub
2012 Apr 18. PMID:
22516416∟.
Bibliometric analysis. ˍ
*
Du
X, Chen C, Xiao Y, Cui Y, Yang L, Li X, Liu X, Wang R, Tan
B.
Research
on application of tumor treating fields in glioblastoma: A
bibliometric and visual analysis.
Front
Oncol. 2022 Nov 10, 2022;12:1055366∟.
doi: 10.3389/fonc.2022.1055366∟.
PMID: 36439464∟.
Bibliometric analysis. ˍ
Supplementary
materials∟.
ˍ
ˍ
Xing Y, Yasinjan F, Cui J, Peng Y, He M, Liu W, Hong
X.
Advancements and current trends in
tumor treating fields: a scientometric analysis.
Int
J Surg. 2024 Feb 13. doi:
10.1097/JS9.0000000000001151. PMID:
38349201. Bibliographic analysis. ˍ
Montes-Escobar K, de la Hoz-M J, Castillo-Cordova P, Duran-Ospina
JP, Bravo-Saltos RK, Lapo-Talledo GJ, Siteneski A.
Glioblastoma:
a comprehensive approach combining bibliometric analysis, Latent
Dirichlet Allocation, and HJ-Biplot : Glioblastoma insights and
trends: a 49-year bibliometric analysis.
Neurosurg
Rev. 2024 May 10;47(1):209. doi:
10.1007/s10143-024-02440-x. PMID:
38724684. Bibliometric analysis˰
ˍ
*Lv K, Du X, Chen C, Yu Y.
Research
hotspots and trend of glioblastoma immunotherapy: a bibliometric
and visual analysis.
Front
Oncol. 2024 Aug 7;14:1361530. doi:
10.3389/fonc.2024.1361530. PMID:
39175478 Bibliometric analysis. ˍ
Huo X, Li H, Xing Y, Liu W, Chen P, Du F, Song L, Yu Z, Cao X,
Tian J.
Two decades of progress in
glioma methylation research: the rise of temozolomide resistance
and immunotherapy insights.
Front
Neurosci. 2024 Sep 2;18:1440756. doi:
10.3389/fnins.2024.1440756. PMID:
39286478. Bibliometric analysis. ˍ
.
Zhang T, Jiang S, Zhang L, Liu Y, Zheng H, Zhao H, Du S, Xu Y, Lu
X.
A bibliometric analysis of
oncolytic virotherapy combined with immunotherapy.
Hum
Vaccin Immunother. 2024 Oct 14;20(1):2406621. doi:
10.1080/21645515.2024.2406621.
PMID:
39400287. Bibliometric analysis. ˍ
Liang R, Hu C, Li H, Tang X.
Research
trends of glioma-related epilepsy: A bibliometric analysis from
2004 to 2023.
J
Cent Nerv Syst Dis. 2024 Oct 16;16:11795735241286653.
doi:
10.1177/11795735241286653. PMID:
39420955. Bibliometric analysis. ˍ
Dai J, Song S, Chen P, Huang Q, Duan H.
Analyzing
research trends in glioblastoma metabolism: a bibliometric review.
Front
Immunol. 2024 Oct 18;15:1444305. doi:
10.3389/fimmu.2024.1444305. PMID:
39493751. Bibiometric analysis. ˍ
Zeng Y, Tao G, Zeng Y, He J, Cao H, Zhang L.
Bibliometric
and visualization analysis in the field of epigenetics and glioma
(2009-2024).
Front
Oncol. 2024 Oct 29;14:1431636. doi:
10.3389/fonc.2024.1431636. PMID:
39534093. Bibliometric analysis. ˍ
Alirezaei Z, Amouheidari A, BasirianJahromi R, Seyyedhosseini S,
Hamidi A.
Survival Analysis of
Glioblastoma: A Scientometric Perspective.
World
Neurosurg. 2024 Nov 20:S1878-8750(24)01919-3? doi:
10.1016/j.wneu.2024.11.059? PMID:
39577630. Bibliometric analysis˰
ˍ
He C, Xiong P, Zeng C, Qiu X, Long T, Song H.
Bibliometric
analysis of the top 100 most cited articles on the immunotherapy
for glioblastoma.
Childs
Nerv Syst. 2024 Dec 5;41(1):33. doi:
10.1007/s00381-024-06693-1. PMID:
39633087. Bibliometric analysis˰
ˍ
Zhang J, Yan X, Gao X, Hu J, Zhao H, Yang C, Xu L, Niu Y, Geng M,
Wang N, Hu S.
Three Decades of
Photodynamic Therapy for Glioblastoma: A Comprehensive
Scientometric Analysis.
Photodiagnosis
Photodyn Ther. 2025 Mar 5:104533. doi:
10.1016/j.pdpdt.2025.104533. PMID:
40054646. Bibliometric analysis. ˍ
Nanomedicine
Pontoriero A, Critelli P, Zeppieri M, Bosurgi A, Guercio S, Caffo
M, Angileri FF, Parisi S, Lavalle S, Pergolizzi S.
Nano-drug
delivery systems integrated with low radiation doses for enhanced
therapeutic efficacy in cancer treatment.
World
J Clin Cases. 2025 Apr 6;13(10):101719. doi:
10.12998/wjcc.v13.i10.101719. PMID:
40191672. Bibliometric abalysis. ˍ
CAR-T immunotherapy
Song Z, Yang C, Gu J, Qu R, Xie Y, Guo Y, Nong X, Chen Z, Wang Z.
The hotspots and publication trends in
glioblastoma and CAR-T immunotherapy: A bibliometric analysis.
Hum
Vaccin Immunother. 2025 Jun 3;21(1):2509483. doi:
10.1080/21645515.2025.2509483. PMID:
40460258. Bibliometric analysis. ˍ
Zhu J, Li X, Lin Z, Qu L, Guan H. 2009-2023
Bibliometric
analysis of the clinical value of graphene quantum dots in
glioblastoma treatment.
Discov
Nano. 2025 Jun 18;20(1):96. doi:
10.1186/s11671-025-04277-9. PMID:
40531247. Bibliometric analysis. ˍ
Yi L, Wang W, Chen Y, Xiong Z, Ma L, Wang Z, Ye W, Li X.
A
bibliometric analysis of global research trends in autophagy and
glioblastomas.
Naunyn
Schmiedebergs Arch Pharmacol. 2025 Sep 17. doi:
10.1007/s00210-025-04578-x. PMID:
40960516. Bibliometric
analysis˰ ˍ
Pan XH, Wang N, He YC, Su J, Gao YF.
Scientometric
analysis of glioblastoma and blood-brain barrier research
(1995-2024): evolving trends and therapeutic challenges.
Front
Oncol. 2025 Sep 25;15:1649414. doi:
10.3389/fonc.2025.1649414. PMID:
41079104. Bibliometric analysis. ˍ
Li J, Lu L, Duan Y, Huang G, Fang X, Deng Y, Tang F, Jiang F, Dai
D.
Global research trends in CAR-T
cell therapy for glioblastoma: a bibliometric and visualized
analysis.
Discov
Oncol. 2025 Sep 29;16(1):1770. doi:
10.1007/s12672-025-03285-6. PMID:
41021151. Bibliometric analysis. ˍ